147 related articles for article (PubMed ID: 10526537)
21. Numerical aberrations of chromosomes 9 and 11 detected by FISH in Greek bladder cancer patients.
Panani AD; Babanaraki A; Malianga E; Roussos Ch
Anticancer Res; 2004; 24(6):3857-61. PubMed ID: 15736422
[TBL] [Abstract][Full Text] [Related]
22. Aberration of chromosomes 8 and 11 in bladder cancer as detected by fluorescence in situ hybridization.
Awata S; Sakagami H; Tozawa K; Sasaki S; Ueda K; Kohri K
Urol Res; 2000 Jun; 28(3):185-90. PubMed ID: 10929427
[TBL] [Abstract][Full Text] [Related]
23. Chromosomal abnormalities in macroscopically normal urothelium in patients with bladder pT1 and pT2a urothelial carcinoma: a fluorescence in situ hybridization study and correlation with histologic features.
Mazzucchelli R; Barbisan F; Stramazzotti D; Montironi R; Lopez-Beltran A; Scarpelli M
Anal Quant Cytol Histol; 2005 Jun; 27(3):143-51. PubMed ID: 16121635
[TBL] [Abstract][Full Text] [Related]
24. Chromosomal aberrations in Cis and Ta bilharzial bladder cancer: a theory of pathogenesis.
Khaled HM; Aly MS; Mokhtar N
Urol Oncol; 2004; 22(6):443-7. PubMed ID: 15610858
[TBL] [Abstract][Full Text] [Related]
25. Chromosomal changes detected by fluorescence in situ hybridization in patients with acute lymphoblastic leukemia.
Zhang L; Parkhurst JB; Kern WF; Scott KV; Niccum D; Mulvihill JJ; Li S
Chin Med J (Engl); 2003 Sep; 116(9):1298-303. PubMed ID: 14527352
[TBL] [Abstract][Full Text] [Related]
26. Nonrandom numerical aberrations of chromosomes 7, 9, and 10 in DNA-diploid bladder cancer.
Matsuyama H; Bergerheim US; Nilsson I; Pan Y; Skoog L; Tribukait B; Ekman P
Cancer Genet Cytogenet; 1994 Oct; 77(2):118-24. PubMed ID: 7954321
[TBL] [Abstract][Full Text] [Related]
27. Fluorescence in situ hybridization detects frequent chromosome 9 deletions and aneuploidy in histologically normal urothelium of bladder cancer patients.
Obermann EC; Meyer S; Hellge D; Zaak D; Filbeck T; Stoehr R; Hofstaedter F; Hartmann A; Knuechel R
Oncol Rep; 2004 Apr; 11(4):745-51. PubMed ID: 15010867
[TBL] [Abstract][Full Text] [Related]
28. Correlation between histologic findings and cytogenetic abnormalities in bladder carcinoma: a FISH study.
Placer J; Espinet B; Salido M; Solé F; Gelabert-Mas A
Urology; 2005 May; 65(5):913-8. PubMed ID: 15882723
[TBL] [Abstract][Full Text] [Related]
29. Chromosome 9 aberrations by fluorescence in situ hybridisation in bladder transitional cell carcinoma.
Eleuteri P; Grollino MG; Pomponi D; De Vita R
Eur J Cancer; 2001 Aug; 37(12):1496-503. PubMed ID: 11506956
[TBL] [Abstract][Full Text] [Related]
30. Polysomies but not Y chromosome losses have prognostic significance in pTa/pT1 urinary bladder cancer.
Neuhaus M; Wagner U; Schmid U; Ackermann D; Zellweger T; Maurer R; Alund G; Knönagel H; Rist M; Moch H; Mihatsch MJ; Gasser TC; Sauter G
Hum Pathol; 1999 Jan; 30(1):81-6. PubMed ID: 9923932
[TBL] [Abstract][Full Text] [Related]
31. Specific chromosome aberrations in peripheral blood lymphocytes are associated with risk of bladder cancer.
Shao L; Lerner SL; Bondaruk J; Czerniak BA; Zeng X; Grossman HB; Spitz MR; Wu X
Genes Chromosomes Cancer; 2004 Dec; 41(4):379-89. PubMed ID: 15390184
[TBL] [Abstract][Full Text] [Related]
32. Characterization of chromosomal abnormalities in uroepithelial carcinomas by G-banding, spectral karyotyping and FISH analysis.
Fadl-Elmula I; Kytölä S; Pan Y; Lui WO; Derienzo G; Forsberg L; Mandahl N; Gorunova L; Bergerheim US; Heim S; Larsson C
Int J Cancer; 2001 Jun; 92(6):824-31. PubMed ID: 11351302
[TBL] [Abstract][Full Text] [Related]
33. Automated quantification of FISH signals in urinary cells enables the assessment of chromosomal aberration patterns characteristic for bladder cancer.
Köhler CU; Martin L; Bonberg N; Behrens T; Deix T; Braun K; Noldus J; Jöckel KH; Erbel R; Sommerer F; Tannapfel A; Harth V; Käfferlein HU; Brüning T
Biochem Biophys Res Commun; 2014 Jun; 448(4):467-72. PubMed ID: 24802410
[TBL] [Abstract][Full Text] [Related]
34. [Fluorescence in situ hybridization in diagnosis of urinary bladder cancer].
Stroganova AM; Khachaturian AV
Arkh Patol; 2006; 68(5):43-6. PubMed ID: 17144532
[TBL] [Abstract][Full Text] [Related]
35. [Detection of chromosomal aberration using fluorescence in situ hybridization in DNA diploid colorectal carcinomas].
Jibiki M; Tagawa Y; Miyashita K; Hara S; Yasutake T; Nakazaki T; Obatake M; Sawai T; Morinaga M; Akama F
Gan To Kagaku Ryoho; 1993 Apr; 20(6):759-62. PubMed ID: 8489281
[TBL] [Abstract][Full Text] [Related]
36. Chromosomal aberrations in benign and malignant bilharzia-associated bladder lesions analyzed by comparative genomic hybridization.
Fadl-Elmula I; Kytola S; Leithy ME; Abdel-Hameed M; Mandahl N; Elagib A; Ibrahim M; Larsson C; Heim S
BMC Cancer; 2002 Mar; 2():5. PubMed ID: 11914143
[TBL] [Abstract][Full Text] [Related]
37. Chromosome 8 numerical aberration and C-MYC copy number gain in bladder cancer are linked to stage and grade.
Mahdy E; Pan Y; Wang N; Malmström PU; Ekman P; Bergerheim U
Anticancer Res; 2001; 21(5):3167-73. PubMed ID: 11848469
[TBL] [Abstract][Full Text] [Related]
38. Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder.
Hartmann A; Schlake G; Zaak D; Hungerhuber E; Hofstetter A; Hofstaedter F; Knuechel R
Cancer Res; 2002 Feb; 62(3):809-18. PubMed ID: 11830537
[TBL] [Abstract][Full Text] [Related]
39. Does topical instillation therapy influence chromosomal aberrations in superficial bladder cancer?
Pycha A; Mian C; Hofbauer J; Haitel A; Wiener H; Marberger M
J Urol; 1998 Jan; 159(1):265-9. PubMed ID: 9400492
[TBL] [Abstract][Full Text] [Related]
40. Fluorescence in situ hybridization evaluation of c-erbB-2 gene amplification and chromosomal anomalies in bladder cancer.
Ohta JI; Miyoshi Y; Uemura H; Fujinami K; Mikata K; Hosaka M; Tokita Y; Kubota Y
Clin Cancer Res; 2001 Aug; 7(8):2463-7. PubMed ID: 11489827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
